loading page

Determination of Zearalenone in Urine Samples from Guatemala:  A Pilot Assessment
  • +7
  • Christian S. Alvarez*,
  • Sean Burke*,
  • Patricia Zaid,
  • Joshua W. Smith,
  • Alvaro Rivera-Andrade,
  • María F. Kroker-Lobos ,
  • Manuel Ramírez-Zea,
  • Michael Dean,
  • Katherine A. McGlynn,
  • John D. Groopman
Christian S. Alvarez*
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, U.S.A.

Corresponding Author:[email protected]

Author Profile
Sean Burke*
Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, U.S.A.
Patricia Zaid
Tecnicas Biológicas, S.A. Biotec, Guatemala City, Guatemala
Joshua W. Smith
Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, U.S.A.
Alvaro Rivera-Andrade
INCAP Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala
María F. Kroker-Lobos
INCAP Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala
Manuel Ramírez-Zea
INCAP Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala
Michael Dean
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, U.S.A.
Katherine A. McGlynn
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, U.S.A.
John D. Groopman
Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, U.S.A., Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, U.S.A.